Publication | Closed Access
Glucagon-like peptide 1 analogue therapy directly modulates innate immune-mediated inflammation in individuals with type 2 diabetes mellitus
228
Citations
10
References
2013
Year
InflammationAutoimmune DiseaseAnalogue TherapyGlucagon-like Peptide 1DiabetesImmunologyType 2Chronic InflammationAutoimmunityInnate ImmunityDiabetes MellitusImmunotherapyMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1